1,304
Views
7
CrossRef citations to date
0
Altmetric
Diabetes

Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective

, , , &
Pages 991-999 | Received 29 Apr 2017, Accepted 20 Jun 2017, Published online: 11 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David J Ramsey, Samuel J Poulin, Lauren C LaMonica, Gregory R Blaha, Fina C Barouch, Jeffrey Chang & Jeffrey L Marx. (2021) Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs. Clinical Ophthalmology 15, pages 31-39.
Read now
Brian Godman, Mainul Haque, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Eleonora Allocati, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Jitendra Acharya, Takuma Sugahara, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Alice Pisana, Janney Wale & Mihajlo Jakovljevic. (2021) Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future. Current Medical Research and Opinion 37:9, pages 1529-1545.
Read now

Articles from other publishers (5)

Thi-Phuong-Lan Nguyen, M. Rifqi Rokhman, Imre Stiensma, Rachmadianti Sukma Hanifa, The Due Ong, Maarten J. Postma & Jurjen van der Schans. (2023) Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review. Frontiers in Public Health 11.
Crossref
Marko Krstic, Jean-Christophe Alain Devaud & Farshid Sadeghipour. (2021) Pharmacists’ considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes. European Journal of Hospital Pharmacy 28:e1, pages e2-e7.
Crossref
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell & Bjorn Wettermark. (2021) Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International 2021, pages 1-16.
Crossref
Francisco J. Barrera, Freddy JK. Toloza, Oscar J. Ponce, Jorge A. Zuñiga-Hernandez, Larry J. Prokop, Nilay D. Shah, Gordon Guyatt, Rene Rodriguez-Gutierrez & Victor M. Montori. (2020) The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes. Endocrine 71:1, pages 47-58.
Crossref
Thales B. C. Silva, Paulo H. R. F. Almeida, Vania E. Araújo, Francisco de Assis Acurcio, Augusto A. Guerra Júnior, Brian Godman & Juliana Alvares. (2018) Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis . Therapeutic Advances in Endocrinology and Metabolism 9:8, pages 241-254.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.